A Pilot Study to Characterize the Household Impact of Locating Devices for Children With ASD Who Wander
NCT03814902 is an interventional trial sponsored by Northwell Health. As of 21 Nov 2026, it is completed. It studies Autism Spectrum Disorder and Wandering Behavior. The registry lists an enrollment of 31 participants at 1 site in 1 country. The registry lists a start date of 15 Jan 2019 and a primary completion date of 11 Nov 2019.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT03814902 |
| Status | Completed |
| Study type | Interventional trial |
| Lead sponsor | Northwell Health |
| Enrollment | 31 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Autism Spectrum Disorder and Wandering Behavior |
| Start | 15 Jan 2019 |
| Primary completion | 11 Nov 2019 |
| Study completion | 11 Nov 2019 |
| Last update posted | 5 Jan 2021 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Andrew Adesman, MD
Northwell Health
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cohen Children's Medical Center of New York
New Hyde Park
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT03814902
Each answer restates registry values shown on this page.
What is NCT03814902?
NCT03814902 is an interventional trial sponsored by Northwell Health. It studies Autism Spectrum Disorder and Wandering Behavior.
Who leads NCT03814902?
The registry names Andrew Adesman, MD (principal investigator, Northwell Health) as the overall official.
Where does NCT03814902 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
When did NCT03814902 end?
The registry lists a primary completion date of 11 Nov 2019 and a study completion date of 11 Nov 2019. The sponsor last updated the record on 5 Jan 2021.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.